Status:
WITHDRAWN
Shape vs Substrate in AF
Lead Sponsor:
Oxford University Hospitals NHS Trust
Conditions:
Atrial Fibrillation
Atrial Fibrillation, Persistent
Eligibility:
All Genders
18+ years
Brief Summary
Atrial fibrillation (AF) is an abnormal heart rhythm which originates from the top two chambers (atria) of the heart. It can cause significant symptoms and have severe consequences such as stroke. Ca...
Detailed Description
This study will utilise the AcQMap system (Acutus Medical). This is a combined multi-electrode and imaging mapping system, with intra chamber ultrasound used to create a surface mesh of a participant'...
Eligibility Criteria
Inclusion
- Retrospective component:
- Participant gave consent for anonymised data being utilised for clinical research at time of procedure.
- Male or Female, aged 18 years or above.
- Previous AcQMap guided ablation for paroxysmal or persistent atrial fibrillation.
- Prospective component:
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Diagnosed with paroxysmal or persistent atrial fibrillation and planned for an AcQMap guided catheter ablation procedure.
Exclusion
- Congenital cardiac abnormality.
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participant at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05993104
Start Date
January 1 2024
End Date
September 1 2026
Last Update
February 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
John Radcliffe Hospital
Oxford, Oxfordshire, United Kingdom, OX3 9DU